Case Study: Streamlining AAV titer determination using variable pathlength technology
Aug
10
2022
On demand

Case Study: Streamlining AAV titer determination using variable pathlength technology

Wednesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Sponsor
Case Study: Streamlining AAV titer determination using variable pathlength technology

Today, one of the primary challenges in the production of consistent quality of recombinant adeno-associated virus (rAAV) remains the fact that current analytical tools are insufficient to meet all needs, due to high variability (CV 20%–40%), low sample throughput, long turnaround times. Process development can be time-consuming, especially when the team requires many development cycles for achieving a robust and consistent comparability between the development lots.

In this webinar, we will discuss a new method for AAV titer determination using real-time monitoring that eliminates the dependecy of off-line testing and associated variability caused by sample manipulation. We will demonstrate how at-line process controls, using variable pathlength technology, can offer quick and direct total viral vector analysis, during development to enhance throughput and improve decision-making.

  • Introduction to Variable Pathlength Technology (VPT) 
  • Addressing PD challenges with a new streamlined method (PTC Therapeutics) 
  • Present AAV titer data demonstrating the CTech SoloVPE System performance (accuracy, linearity, repeatability)

Yan Chen PhD

Principal Scientist, Downstream Process Development, PTC Therapeutics

Yan Chen is a principal scientist in Downstream Process Development- Gene Therapy at PTC Therapeutics. He has more than 14 years of experience in the biologics field. Yan has worked at several biotech and pharmaceutical companies and developed purification processes for biologics, including mAbs, recombinant proteins, and viral vectors. His expertise includes downstream process development for early and late stage programs, technology transfer, and process characterization. He received his PhD in Cell Biology from New York University.


Joe Ferraiolo

Associate Director, Bioanalytics, Repligen

Joe leads the bioanalytics applications team and is in charge of the SoloVPE variable pathlength spectroscopy system for at-line applications. He has been with the company for more than 20 years, with over ten years of development and validation experience in analytical applications. He specializes in UV analysis and leads the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologics.


Yan Chen PhD
Yan Chen PhD
PTC Therapeutics Inc

Yan Chen is a principal scientist in Downstream Process Development- Gene Therapy at PTC Therapeutics. He has more than 14 years of experience in the biologics field. Yan has worked at several biotech and pharmaceutical companies and developed purification processes for biologics, including mAbs, recombinant proteins, and viral vectors. His expertise includes downstream process development for early and late stage programs, technology transfer, and process characterization. He received his PhD in Cell Biology from New York University.

Joseph Ferraiolo
Joseph Ferraiolo
Associate Director, Bioanalytics at

Joe leads the bioanalytics applications team and is in charge of the SoloVPE variable pathlength spectroscopy system for at-line applications. He has been with the company for more than 20 years, with over ten years of development and validation experience in analytical applications. He specializes in UV analysis and leads the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologics.

SPEAKERS

Yan Chen PhD
Yan Chen PhD
PTC Therapeutics Inc
Joseph Ferraiolo
Joseph Ferraiolo
Associate Director, Bioanalytics at

You might also like

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Emily Neil, Ariadna Pascual
27 June
in 70
Days
Register
Pure and simple: understanding LNP analytics for better mRNA-based drugs

Pure and simple: understanding LNP analytics for better mRNA-based drugs

Adam Crowe
29 May
in 41
Days
Register
Empowering patient care: in-process and quality control solutions for cellular therapies

Empowering patient care: in-process and quality control solutions for cellular therapies

Christin Tischner, Simon Lennartz
23 May
in 35
Days
Register
T cells from beginning to end: optimizing leukopak and drug product cryopreservation

T cells from beginning to end: optimizing leukopak and drug product cryopreservation

Meredith Safford, ShaNelle Yelity
22 May
in 34
Days
Register
Mastering AAV production: best practices For small- to large-scale manufacturing success and reduced development time

Mastering AAV production: best practices For small- to large-scale manufacturing success and reduced development time

Emily Jackson-Holmes
21 May
in 33
Days
Register